Main Article Content


The phenomenon of off-label drug use has been widely observed in the pediatric population, including in Indonesia. The major concern arising from the prevalence of off-label drug use is the increased risk of adverse drug reactions. We performed a systematic review to describe and provide insight into off-label pediatric drug use in Indonesia. The articles published using English and Bahasa Indonesia were systematically searched in five electronic databases including Pubmed, Scopus, Google Scholar, Garuda, and Neliti. Key terms used for the search were as follows: “off-label use”, “off-label, “child", "pediatrics", "infant", "adolescent", ”newborn”, “Indonesia”. A total of 116 studies were initially obtained from electronic databases. Further, after the references were reviewed, 10 articles met all the eligibility criterias were finally selected. The percentage of off-label pediatric drug use was 32.6-89.9%. The off-label categories in the selected studies were age, dosage, contraindication, route of administration, and indication. Among these off-label categories, age was the highest off-label with percentages ranged from 19.8 to 92.9%. Pseudoephedrine hydrochloride and triamcinolone acetonide became the most frequently used drug in that category. Thus we conclude that off-label pediatric drug use is common in Indonesia. Future research should consider the safety of off-label drugs in pediatric, primarily in Indonesia. Clinicians should aware of off-label drugs in pediatric and consider the risk-benefit of the drugs when prescribing to children. The authorities need to regulate the off-label drug prescribing in pediatric, therefore could improve medication safety and quality.



Off-Label Drug Pediatric Indonesia Systematic Review

Article Details


  1. Abdulah, R., Khairinisa, M. A., Pratiwi, A. A., Barliana, M. I., Pradipta, I. S., Halimah, E., Diantini, A., & Lestari, K. (2015). Off-label paediatric drug use in an Indonesian community setting. Journal of Clinical Pharmacy and Therapeutics, 40(4), 409–412.
  2. Akbar, R., Setyaningrum, N., & Estiningsih, D. (2017). Kajian Penggunaan obat off-label pada Anak di Puskesmas Sleman. INPHARNMED Journal (Indonesian Pharmacy and Naturan Medicine Journal), 1(1), 21–33.
  3. Ariati, A. L., Kartinah, N., & Intannia, D. (2015). Gambaran Penggunaan Obat Off-Label Pada Pasien Pediatrik Rawat Jalan Di RSUD Ulin Banjarmasin Periode Januari-Desember 2013. Jurnal Pharmascience, 2(1), 58–64.
  4. Balan, S., Azmi, M., Hassali, A., & Mak, V. S. L. (2018). Two decades of off ‑ label prescribing in children : a literature review. World Journal of Pediatrics, 14(6), 528–540.
  5. Bellis, J. R., Kirkham, J. J., Nunn, A. J., & Pirmohamed, M. (2013). Adverse drug reactions and off-label and unlicensed medicines in children : a prospective cohort study of unplanned admissions to a paediatric hospital. British Journal of Clinical Pharmacology, 77(3), 543–553.
  6. Corny, J., Lebel, D., Bailey, B., & Bussières, J.-F. (2015). Unlicensed and Off-Label Drug Use in Children Before and After Pediatric Governmental Initiatives. J Pediatr Pharmacol Ther, 20(4), 316–328.
  7. Delmas, S., Bourdon, O., Brion, F., & Prot-labarthe, S. (2016). Unlicensed and off-label medicines and prescriptions : A descriptive analysis of the medicines formulary and of the 56 , 800 prescriptions in a paediatric hospital. Pediatric Dimensions, 1(1), 46–52.
  8. Easwaran, V., Satrasala, B. P., & Mallela, S. (2017). A study on off ‑ label and unlicensed drug use by community pharmacists : A report from resource ‑ limited settings of South India. Journal of Health Research and Reviews, 4(1), 19–23.
  9. Fitzsimons, R., Poel, L. Van Der, Thornhill, W., Toit, G., Shah, N., & Brough, H. A. (2015). Antihistamine use in children. Arch Dis Child Educ Pract Ed, 100, 122–131.
  10. Gaillard, T., Briolant, S., Madamet, M., & Pradines, B. (2017). The end of a dogma : the safety of doxycycline use in young children for malaria treatment. Malaria Journal, 16(148), 1–5.
  11. Hada, N., & Ashawat, M. (2014). Ethical Conduct of Paediatric Clinical Trials; Issues and Challenges. Research Journal of Pharmaceutical Dosage Forms and Technology, 6(3), 156–160.
  12. Hapsari, R. I. A., Aini, S. R., & Hamdin, C. D. (2018). Penggunaan Obat Off-Label pada Pasien Anak di Rumah Sakit Umum ( The Off-Label Drug Use in Children at General Hospital Nusa Tenggara Barat in 2017 ). Mataram University.
  13. Hawker, S., Payne, S., Kerr, C., Hardey, M., & Powell, J. (2015). Appraising the Evidence : Reviewing Disparate Data Systematically. Qualitative Helath Research, 12(9), 1284–1299.
  14. Joseph, P. D., Craig, J. C., & Caldwell, P. H. Y. (2013). Clinical trials in children. British Journal of Clinical Pharmacology, 79(3), 357–369.
  15. Kartinah, N., Intannia, D., & Fitri, N. (2014). Overview Off-label Drug Uses in Pediatric Patients at Ulin’s Hospital , Banjarmasin. Jurnal Farmasi Klinik Indonesia, 3(3), 77–81.
  16. Khan, S. N., Joseph, S., & Sasidharan, P. (2016). A study of clinical pharmacist initiated intervention for the optimal use of medications in a neonatal intensive care unit (NICU) of a tertiary care hospital, south India. International Journal of Pharmacy and Pharmaceutical Sciences, 8(1), 23–26.
  17. Kimland, E., & Odlind, V. (2012). Off-Label Drug Use in Pediatric Patients. Clinical Pharmacology and Therapeutics, 91(5), 796–801.
  18. Knopf, H., Wolf, I., Sarganas, G., Zhuang, W., Rascher, W., & Neubert, A. (2013). Off-label medicine use in children and adolescents : results of a population-based study in Germany. BMC Public Health, 13(631), 1–12.
  19. Lorenc, T., Petticrew, M., Whitehead, M., Neary, D., Clayton, S., Wright, K., … Renton, A. (2014). Crime, fear of crime and mental health: synthesis of theory and systematic reviews of interventions and qualitative evidence. Public Health Research, 2(2), 1–398.
  20. Mason, J., Pirmohamed, M., & Nunn, T. (2012). Off-label and unlicensed medicine use and adverse drug reactions in children : a narrative review of the literature. Eur J Clin Pharmacol, 68, 21–28.
  21. Mir, A. N., & Geer, M. I. (2016). Off-Label Use of Medicines In Children. International Journal of Pharmaceutical Sciences and Research, 7(5), 1820–1828.
  22. Motola, D., Cipriani, F., Calamelli, E., Vaccheri, A., & Ricci, G. (2017). Safety profile of H1 ‐ antihistamines in pediatrics : an analysis based on data from VigiBase. Pharmacoepidemiol Drug Saf, 25, 1–8.
  23. Mukattash, T. L., Alzoubi, K. H., Abuirjie, A. M., Jarab, A. S., Abu, R. K., Nusair, M. B., & Mcelnay, J. C. (2018). Perceptions and attitudes towards off-label dispensing for pediatric patients , a study of hospital based pharmacists in Jordan. Saudi Pharmaceutical Journal, 26(1), 20–24.
  24. Nithya, S., & Rani Mohan, M. (2016). A study on development and evaluation of a paediatric formulary in a Tertiary care hospital. Research Journal of Pharmacy and Technology, 9(11), 1957–1961.
  25. Palmaro, A., Bissuel, R., Renaud, N., & Durrieu, G. (2015). Off-Label Prescribing in Pediatric Outpatients. Pediatrics, 135(1), 49–58.
  26. Park, M. S. (2014). Off-label use and designation of age groupspecific